MiMedx Group, Inc. Operating Lease, Right-of-Use Asset, Amortization Expense
MiMedx Group, Inc. (MDXG) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $664.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-07-29
- MiMedx Group, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $334.00K, a 7.05% increase year-over-year.
- MiMedx Group, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $330.00K, a 7.49% increase year-over-year.
- MiMedx Group, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $325.00K, a 3.85% decline year-over-year.
- MiMedx Group, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $318.00K, a 3.93% decline year-over-year.
- MiMedx Group, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $1.26M, a 3.66% decline from fiscal 2024.
- MiMedx Group, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $1.31M, a 3.31% increase from fiscal 2023.
- MiMedx Group, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $1.27M, a 0.71% increase from fiscal 2022.
- MiMedx Group, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $1.26M, a 27.30% increase from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $334.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $664.00K 10-Q · filed 2026-07-29 | $989.00K derived: sum of 3 quarters · filed 2026-07-29 | $1.31M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $330.00K 10-Q · filed 2026-04-29 | $655.00K derived: sum of 2 quarters · filed 2026-04-29 | $973.00K derived: sum of 3 quarters · filed 2026-04-29 | $1.28M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $325.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $643.00K derived: sum of 2 quarters · filed 2026-02-25 | $955.00K derived: sum of 3 quarters · filed 2026-07-29 | $1.26M 10-K · filed 2026-02-25 |
| 2025-09-30 | $318.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $630.00K derived: sum of 2 quarters · filed 2026-07-29 | $937.00K 10-Q · filed 2025-10-29 | $1.27M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $312.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $619.00K 10-Q · filed 2026-07-29 | $957.00K derived: sum of 3 quarters · filed 2026-07-29 | $1.29M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $307.00K 10-Q · filed 2026-04-29 | $645.00K derived: sum of 2 quarters · filed 2026-04-29 | $976.00K derived: sum of 3 quarters · filed 2026-04-29 | $1.30M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $338.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $669.00K derived: sum of 2 quarters · filed 2026-02-25 | $993.00K derived: sum of 3 quarters · filed 2026-02-25 | $1.31M 10-K · filed 2026-02-25 |
| 2024-09-30 | $331.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $655.00K derived: sum of 2 quarters · filed 2025-10-29 | $972.00K 10-Q · filed 2025-10-29 | $1.28M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $324.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $641.00K 10-Q · filed 2025-07-30 | $950.00K derived: sum of 3 quarters · filed 2026-02-25 | $1.25M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $317.00K 10-Q · filed 2025-04-30 | $626.00K derived: sum of 2 quarters · filed 2026-02-25 | $927.00K derived: sum of 3 quarters · filed 2026-02-25 | $1.25M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $309.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $610.00K derived: sum of 2 quarters · filed 2026-02-25 | $934.00K derived: sum of 3 quarters · filed 2026-02-25 | $1.27M 10-K · filed 2026-02-25 |
| 2023-09-30 | $301.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $625.00K derived: sum of 2 quarters · filed 2024-10-30 | $959.00K 10-Q · filed 2024-10-30 | $1.29M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $324.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $658.00K 10-Q · filed 2024-07-31 | $986.00K derived: sum of 3 quarters · filed 2025-02-26 | $1.31M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $334.00K 10-Q · filed 2024-04-30 | $662.00K derived: sum of 2 quarters · filed 2025-02-26 | $983.00K derived: sum of 3 quarters · filed 2025-02-26 | $1.30M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $328.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $649.00K derived: sum of 2 quarters · filed 2025-02-26 | $964.00K derived: sum of 3 quarters · filed 2025-02-26 | $1.26M 10-K · filed 2025-02-26 |
| 2022-09-30 | $321.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-30 | $636.00K derived: sum of 2 quarters · filed 2023-10-30 | $931.00K 10-Q · filed 2023-10-30 | $1.20M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $315.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $610.00K 10-Q · filed 2023-08-01 | $875.00K derived: sum of 3 quarters · filed 2024-02-28 | $1.12M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $295.00K 10-Q · filed 2023-05-02 | $560.00K derived: sum of 2 quarters · filed 2024-02-28 | $804.00K derived: sum of 3 quarters · filed 2024-02-28 | $1.05M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $265.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $509.00K derived: sum of 2 quarters · filed 2024-02-28 | $752.00K derived: sum of 3 quarters · filed 2024-02-28 | $989.00K 10-K · filed 2024-02-28 |
| 2021-09-30 | $244.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $487.00K derived: sum of 2 quarters · filed 2022-11-02 | $724.00K 10-Q · filed 2022-11-02 | $1.00M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $243.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $480.00K 10-Q · filed 2022-08-02 | $761.00K derived: sum of 3 quarters · filed 2023-02-28 | |
| 2021-03-31 | $237.00K 10-Q · filed 2022-05-03 | $518.00K derived: sum of 2 quarters · filed 2023-02-28 | ||
| 2020-12-31 | $281.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $983.00K 10-K · filed 2023-02-28 | ||
| 2020-09-30 | $702.00K 10-Q · filed 2021-11-02 | |||
| 2020-03-31 | $239.00K 10-Q · filed 2021-04-28 | |||
| 2019-12-31 | $947.00K 10-K · filed 2021-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |